معرفی
Dr. Gary Altwerger is an Assistant Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine. He specializes in gynecologic oncology, focusing on advanced surgical techniques for uterine, ovarian, and vulvar cancers, including minimally invasive approaches. His research bridges clinical and basic science, with a focus on biomarker identification in uterine cancer and novel therapies for chemotherapy-resistant tumors. Dr. Altwerger leads clinical trials, such as those evaluating desensitization protocols for carboplatin hypersensitivity and antibody-drug conjugates. He is also involved in surgical skill development through the CSATS platform and chairs the Gynecologic Oncology Morbidity and Mortality meetings. His education includes an MD from the University at Buffalo and residency/fellowship at Yale University.
- Education:
- BS in Biochemistry & Molecular Biology, State University of Albany (2007)
- MD, University at Buffalo Jacobs School of Medicine (2012)
- Residency in Obstetrics & Gynecology, Yale University (2016)
- Fellowship in Gynecologic Oncology, Yale University (2019)
Research Interests: His work spans treatment-resistant uterine cancers, DNA repair pathways, and clinical trials for new therapies. Notable contributions include developing biomarkers for targeted treatments and pioneering surgical techniques like laparoscopic pancreatic peritonectomy.
Clinical Trials: Dr. Altwerger is sub-investigator in trials exploring therapies for cervical, endometrial, and ovarian cancers, including sacituzumab govitecan and afatinib. These trials emphasize personalized medicine and innovative drug combinations.
- Awards:
- Laxmi Baxi Award (2018)
- John J. Meehan-Clifford R. Miller Award (2016)
- Resident Teaching Award (2014)
Labs/Teams: Active in the Gynecologic Oncology Program and Hepatic Arterial Infusion (HAI) Program at Yale Cancer Center. Collaborates on translational research initiatives and institutional review board (IRB) oversight.
